FOLLICULAR LYMPHOMA
Clinical trials for FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental NK cell cocktail aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis early-phase trial tests a combination of two antibody drugs (rituximab and tafasitamab) plus donated natural killer (NK) immune cells for people with B-cell non-Hodgkin lymphoma that has returned or not responded to at least two prior treatments. Up to 15 participants will r…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New combo therapy aims to outsmart follicular lymphoma
Disease control Not yet recruitingThis study tests two drugs, mosunetuzumab and zeprumetostat, together for people with follicular lymphoma, a type of blood cancer. About 80 adults will join, including those newly diagnosed and those whose cancer returned. The goal is to see if the combination can shrink tumors a…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:49 UTC
-
New drug cocktail aims to control follicular lymphoma without chemo
Disease control Not yet recruitingThis study tests a combination of three drugs (orelabrutinib, tafasitamab, and lenalidomide) as a first treatment for people with follicular lymphoma, a slow-growing blood cancer. The goal is to see how well the drugs shrink or eliminate tumors and to check for side effects. Abou…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
New shot could be first treatment for Slow-Growing blood cancer
Disease control Not yet recruitingThis study tests a drug called mosunetuzumab, given as a shot under the skin, for people with a type of slow-growing blood cancer (follicular lymphoma) that has not been treated before and has a low tumor burden. About 30 adults will receive the drug for up to 8 cycles (about 6 m…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New drug trial offers hope for Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study is testing a new injection called TQB2825 against standard immunotherapy for people with follicular lymphoma that has returned or hasn't responded to previous treatments. The main goal is to see which treatment keeps the cancer from getting worse for a longer time. Res…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Apr 14, 2026 13:09 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study looks at how to safely test for allergic reactions to biotherapy drugs in cancer patients. Researchers will find the highest skin test dose that does not cause irritation in most people. The goal is to create clear guidelines for doctors to diagnose allergies to these …
Matched conditions: FOLLICULAR LYMPHOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC